Clinical trial
A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas
NCT03309319 is registered in ClinicalTrials.gov with Zhaoyun Zhang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas
- Lead sponsor
- Zhaoyun Zhang
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 16, 2016
- Completion date
- December 31, 2018
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pituitary tumor